Join
Live feed
·
PRReleasevia Quantisnow
ImmunoPrecise Antibodies Ltd. logo

ImmunoPrecise Antibodies (IPA) Reports Full Fiscal Year 2025 Results, Record Fourth Quarter Revenue, and Record Fourth Quarter Adjusted EBITDA

ByQuantisnow·Wall Street's wire, on your screen.
IPA· ImmunoPrecise Antibodies Ltd.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IPA (ImmunoPrecise Antibodies Ltd.) and more on Quantisnow.